
Development Of Tpst Inhibitors As Non-Hormonal Male ContraceptivesAward last edited on: 6/27/08
Sponsored Program
SBIRAwarding Agency
NIH : NICHDTotal Award Amount
$146,456Award Phase
1Solicitation Topic Code
-----Principal Investigator
Penny M JohnsonCompany Information
Siwa Biotech Corporation
755 Research Parkway Suite 125
Oklahoma City, OK 73104
Oklahoma City, OK 73104
(405) 290-7305 |
N/A |
N/A |
Location: Single
Congr. District: 05
County: Oklahoma
Congr. District: 05
County: Oklahoma
Phase I
Contract Number: 1R43HD055696-01A1Start Date: 00/00/00 Completed: 00/00/00
Phase I year
2008Phase I Amount
$146,456Project narrative:
The project described in this application is eligible and most suited for this SBIR Phase I award because; 1) the project seeks to develop a novel, non-hormonal male contraceptive, 2) there are no FDA-approved oral male contraceptives and this is a large market currently not serviced by any remedy, 3) the applicant company, Siwa Biotech Corp., is a small business in the State of Oklahoma, and the award will initiate the development of a therapeutic product that requires clinical evaluation and FDA approval, 4) the award will allow the identification of lead compounds and provide needed funding to bring this product to the commercial market in a timely fashion; and 5) the product being developed has the potential to contribute considerably to the economy of the State of Oklahoma and the nation, as well as to the enhancement of public health.
Public Health Relevance:
This Public Health Relevance is not available.
Thesaurus Terms:
There Are No Thesaurus Terms On File For This Project.
Phase II
Contract Number: ----------Start Date: 00/00/00 Completed: 00/00/00